4Liby P,Ridker PM,Hansson GK.Progress and challenges in translating the biology of atherosclerosis[J].Nature,2011,473(7347):317-325.
5Mello AP,da Silva IT,Abdalla DS,et al.Electronegative low-density lipoprotein:origin and impact on health and disease[J].Atherosclerosis,2011,215(2):257-265.
6Peters SA,Grobbee DE,Bots ML.Carotid intima-media thickness:a suitable alternative for cardiovascular risk as outcome[J].Eur J Cardiovasc Prev Rehabil,2011,18(2):167-174.
7Tziomalos K,Athyros VG,Karagiannis A,et al.Dyslipidemia as a risk factor for ischemic stroke[J].Curr Top Med Chem,2009,9(14):1291-1297.
8Nedeljkovie ZS,Gokee N,Losealzo J.Mechanismsof oxidative stress and vascular dysfunction[J].Post grad Med J,2003,79(930):195-200.
9Sakurai K,Sawamura T.Stress and vascular responses:endothelial dysfunction via Lectin-like oxidized low-density lipoprotein receptor-1:close relationships with oxidative stress[J].J Pharmacol Sci,2003,91(3):182-186.
10Mehta JK,Chen J,Hermonat PL,et al.Lectin-like oxidized low-density lipoprotein receptor-l(LOX-1):A critical player in the development of atherosclerosis and related disorders[J].Cardiovasc Res,2006,69(1):36-45.
